| pubmed-article:19201647 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19201647 | lifeskim:mentions | umls-concept:C0036019 | lld:lifeskim |
| pubmed-article:19201647 | lifeskim:mentions | umls-concept:C0752121 | lld:lifeskim |
| pubmed-article:19201647 | lifeskim:mentions | umls-concept:C0439830 | lld:lifeskim |
| pubmed-article:19201647 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:19201647 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19201647 | pubmed:dateCreated | 2009-3-31 | lld:pubmed |
| pubmed-article:19201647 | pubmed:abstractText | A characteristic feature of spinocerebellar ataxia type 2 (SCA2) is saccadic slowing at early disease stages. We sought to determine whether this sign is detectable before clinical manifestation and quantifies the disease progression throughout life in linear fashion. | lld:pubmed |
| pubmed-article:19201647 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19201647 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19201647 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19201647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19201647 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19201647 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19201647 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19201647 | pubmed:issn | 1872-8952 | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:AbeleMM | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:FetterMM | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:KlockgetherTT | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:AuburgerGG | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:ZiemannUU | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:TejedaRR | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:SeifriedCC | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Velázquez-Pér... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:WirjatijasaFF | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Sánchez-CruzG... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Santos-Falcón... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Rodríguez-Día... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Rodríguez-Lab... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Almaguer-Mede... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Canales-Ochoa... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Medrano-Monte... | lld:pubmed |
| pubmed-article:19201647 | pubmed:author | pubmed-author:Laffita-MesaJ... | lld:pubmed |
| pubmed-article:19201647 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19201647 | pubmed:volume | 120 | lld:pubmed |
| pubmed-article:19201647 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19201647 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19201647 | pubmed:pagination | 632-5 | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:meshHeading | pubmed-meshheading:19201647... | lld:pubmed |
| pubmed-article:19201647 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19201647 | pubmed:articleTitle | Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. | lld:pubmed |
| pubmed-article:19201647 | pubmed:affiliation | Centro para la Investigación y Rehabilitación de las Ataxias Hereditarias (CIRAH), Holguín, Cuba. | lld:pubmed |
| pubmed-article:19201647 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19201647 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
